Letter | Published:

A candidate gene for the mouse mutation tubby

Nature volume 380, pages 534538 (11 April 1996) | Download Citation

Subjects

Abstract

A MUTATION in the tub gene causes maturity-onset obesity, insulin resistance1, and sensory deficits2,3. In contrast to the rapid juvenile-onset weight gain seen in diabetes (db) and obese (ob) mice, obesity in tubby mice develops gradually, and strongly resembles the late-onset obesity seen in the human population. Excessive deposition of adipose tissue eventually leads to a twofold increase of body weight. Tubby mice also suffer retinal degeneration and neurosensory hearing loss2,3. The tripartite character of the tubby phenotype shows striking similarity to human obesity syndromes, such as Alström4 and Bardet-Biedl5. Here we report the identification of a G -→ T transversion in a candidate gene that abolishes a donor splice site in the 3′ coding region and results in a larger transcript containing the unspliced intron. This alteration is predicted to replace the 44-carboxy-terminal amino acids with a 20-amino-acid sequence not found in the wild-type protein. Additionally, a second, prematurely truncated transcript with the unspliced intron is observed in testis messenger RNA and a 2–3-fold increase in brain mRNA is observed in tubby mice compared to B6. The phenotypic features of tubby mice may be the result of cellular apoptosis triggered by expression of the mutated tub gene.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & J. Heredity 81, 424–427 (1990).

  2. 2.

    et al. Proc. natn. Acad. Sci. U.S.A. 92, 11100–11104 (1995).

  3. 3.

    et al. NeuroReport 6, 845–849 (1995).

  4. 4.

    , , , & Acta psychiat. neurol. scand. 129, 1–35 (1959).

  5. 5.

    Obesity Res. 3, 383–403 (1995).

  6. 6.

    , , , & Genomics 14, 197–199 (1992).

  7. 7.

    et al. Mamm. Gen. 4, 466–474 (1993).

  8. 8.

    Current Protocols in Human Genetics (eds Dracopoli, N. C. et al.) 6.3.1–13 (Current Protocols, New York, 1994).

  9. 9.

    , , , & Genomics 28, 549–559 (1995).

  10. 10.

    , , , & J. molec. Biol. 215, 403–410 (1990).

  11. 11.

    & Biochim. biophys. Acta 1217, 203–206 (1994).

  12. 12.

    et al. Nature 368, 32–38 (1994).

  13. 13.

    Physiol. Rev. 75, 725–748 (1995).

  14. 14.

    , , & J. biol. Chem. 261, 16811–16817 (1986).

  15. 15.

    et al. Nature 347, 677–680 (1990).

  16. 16.

    , & Prog. Ret. Eye Res. 13, 31–64 (1994).

  17. 17.

    Biochem. Cell Biol. 72, 489–498 (1994).

  18. 18.

    et al. Nature Genet. 7, 220–245 (1994).

  19. 19.

    et al. Nature Genet. 10, 135–141 (1995).

  20. 20.

    , & Proteins Struct. Funct. Genet. 9, 180–190 (1991).

Download references

Author information

Affiliations

  1. The Jackson Laboratory, 600 Main Street, Bar Harbor, Maine 04609, USA

    • Konrad Noben-Trauth
    • , Juergen K. Naggert
    •  & Patsy M. Nishina
  2. Sequana Therapeutic Inc., La Jolla, California 92037, USA

    • Michael A. North

Authors

  1. Search for Konrad Noben-Trauth in:

  2. Search for Juergen K. Naggert in:

  3. Search for Michael A. North in:

  4. Search for Patsy M. Nishina in:

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/380534a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.